Industry Context

Specialty chemicals customers increasingly require process-capability reporting as part of supplier qualification, with Cpk typically required at 1.33 or higher and many high-spec applications demanding 1.67+. Industry data shows advanced process control deployments delivering 28% average improvement in product quality consistency and 34% reduction in process variability — yet most specialty batch operations still rely heavily on operator recipe execution and post-hoc SPC. The regulatory frame is also moving: FDA's ICH Q13 guideline on continuous manufacturing (finalised November 2022, FDA implementation March 2023, EMA effective July 2023) formalises expectations for residence-time distribution understanding, real-time variability management and robust diversion of out-of-spec material — and these expectations are flowing back into the batch-process supplier base through pharma and electronics scorecards. The gap between what's achievable and what's deployed is the opportunity.

Problem Statement

• Cpk below 1.33 on key parameters (viscosity, particle size, residual monomer, colour) on a meaningful share of SKUs, exposing the plant to audit findings and rebate cliffs.
• Operator-to-operator variation drives 30–50% of total batch variance for many chemistries, with shift-to-shift addition rates and quality-call interpretation as systematic contributors.
• Off-spec batches trigger costly rework, blending or disposal — typically USD 30–150k per failed batch — plus customer line-stoppage exposure when the batch reaches a downstream user.
• Customer audits increasingly require capability evidence rather than ad-hoc certificates of analysis; pharma and semiconductor customers now run quarterly Cpk reviews on key supplier parameters.
• Equipment ageing and feedstock-lot variation erode the locked recipe over months and quarters, with no automated feedback loop to compensate.

Why Traditional Approaches Fail

Conventional SPC is post-hoc: control charts identify drift after batches are off-spec. PID and even classical APC respond to current state without anticipating recipe-level interactions or feedstock variability. Application of SPC to batch units is well-studied but inherently reactive; the leading causes of variability — operator handoff, feedstock variation, equipment ageing — sit upstream of the control loop. Classical APC tightens a current controller around a fixed recipe, but it does not optimise the recipe itself. Recipe-level decisions — addition rate, ramp profile, sample-and-decide points, hold times — dominate the variance picture and are almost never under formal control.

The Simreka Solution

1. Process Simulation

Process Simulation builds a digital twin of the batch unit and runs every recipe forward in software before execution. The output is a predicted spec-distribution per batch — not just a setpoint — and the operating window that holds Cpk above target across feedstock-lot, shift and equipment-state combinations.

2. Hybrid Modelling

Hybrid Modelling couples the physics-based twin with ML surrogates trained on the plant historian. Operator-driven and feedstock-driven variance, equipment ageing and seasonality all feed in, so predictions reflect real-plant behaviour. Shadow surrogates predict the secondary feedstock effects that CoA reports never capture.

3. Databank

The Databank holds historical batch records, certificate-of-analysis history per feedstock supplier and customer-spec history, supporting per-customer Cpk reporting and ICH Q13-style residence-time-distribution evidence for the regulated portfolio.

Step-by-Step

1. Identify the SKUs and parameters with Cpk below target.
2. Process Simulation builds the batch-unit twin including kinetics, mass and heat transfer.
3. Hybrid Modelling calibrates against plant historian, feedstock variation and operator data.
4. MPC and recipe-level optimisation generated for each SKU; predicted spec distribution is logged before execution.
5. Top recipe variants validated on plant; control loop deployed.
6. Continuous learning — every batch sharpens the twin.

Simreka workflow for virtual batch process control — from low-Cpk identification to deployed loop.

Simulation Workflow

• Data ingestion: plant historian, batch records, feedstock CoAs, customer-spec history, equipment-maintenance log.
• Model creation: hybrid batch-reactor twin with kinetics, heat transfer and mixing, plus operator and feedstock surrogates.
• Iterative optimisation: recipe-level MPC against Cpk and yield, with Pareto trade-off against batch time.
• Scenario testing: feedstock-lot variability, operator handoff, ambient and seasonal effects, cleaning-cycle drift.

Expected Outcomes

• ~40% reduction in batch-to-batch variance on targeted parameters, mirroring deployed APC benchmarks.
• Cpk lifted from 1.0–1.2 baseline to 1.5–1.8 typical on regulated parameters.
• Off-spec batch rate cut 60–80% on covered SKUs.
• Defensible evidence package supporting customer audits, ISO 9001 reviews and ICH Q13-aligned pharma scorecards.

Consistency stops being a quality afterthought and becomes a designed-in property of every recipe.

Fill in the form on the left to access the full document.

FAQs

Q1. What Cpk target does Simreka's Process Simulation realistically deliver on specialty batch reactors?

Most specialty customers ask for Cpk ≥ 1.33 minimum and 1.67 for six-sigma-grade processes. Simreka programmes typically lift Cpk from a 1.0–1.2 baseline to 1.5–1.8 on regulated parameters (viscosity, residual monomer, Mw, colour), with the predicted spec distribution logged before execution rather than checked at batch end.

Q2. How does Hybrid Modelling's shadow surrogate handle feedstock-lot variability the CoA doesn't capture?

The shadow surrogate ingests historian-tagged lot effects and learns the secondary attributes (trace impurities, particle distribution, residual water) that drive process behaviour but rarely appear on the CoA. Each incoming lot receives a predicted process-impact score before consumption, so the MPC layer pre-adjusts recipe and operations gets a goods-inwards decision support, not a post-mortem.

Q3. How does Simreka's stack differ from the classical APC we already run?

Classical APC tightens loop-level control around a fixed recipe. Simreka's Process Simulation plus Hybrid Modelling plus recipe-level MPC optimises the recipe itself — addition rate, ramp profile, sample-and-decide points, hold times — against predicted future Cpk and yield. The result is 35–45% variance reduction versus the 20–30% typical of classical APC alone.

Q4. Does the system support ICH Q13 residence-time-distribution and real-time variability expectations for our pharma intermediates?

Yes. The twin tracks residence-time distribution and transient effects explicitly per batch, with the Databank retaining the evidence pack required for ICH Q13-aligned reviews. Out-of-spec material is identified pre-execution by the predicted distribution and diverted before it reaches downstream finishing or the customer, supporting the diversion strategy ICH Q13 explicitly expects from a continuous-manufacturing-aligned control approach.

Q5. What ROI does a 20–40 SKU plant see from rolling out Simreka virtual process control?

For a plant running 20–40 SKUs with 5–15 off-spec batches/year at USD 30–150k each, eliminating 60–80% saves USD 0.5–2 million/year directly. Retained customer revenue from improved supplier scorecards typically adds a multiple on top, particularly on pharma and semiconductor SKUs where delisting risk is concentrated. Payback for the deployment phase is typically 6–12 months.

Q6. Does the Databank support per-customer Cpk reporting and audit-ready evidence packs?

Yes. Databank retains every batch's predicted-vs-actual distribution, recipe variant, operator and feedstock lot, indexed by customer and SKU. The quarterly Cpk dashboard a pharma or semiconductor customer requests becomes a query, not a project — and the evidence pack supporting an audit is generated as a workflow by-product.

Sources

1. Northwest Analytics — SPC for Batch and Specialty Chemicals
2. ScienceDirect — Application of SPC to Batch Units
3. Zero Instrument — APC Overview and Benefits
4. Honeywell — Advanced Process Control
5. SixSigma.us — Cpk Process Capability Index
6. ISA InTech — Specialty Chemicals Reliable Batch Processing
7. FDA — ICH Q13 Continuous Manufacturing Guideline
8. ICH — Q13 Step 4 Final Guideline (2022)